Search

everythinglearnresearchcommunity

for

Search:↓

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Exercising women should be screened for anemia due to its prevalence and impact on performance.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

PCOS increases sexual pain and distress in infertile Iranian women.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Menopause reduces skin fat, but treatments like magnolol and PLLA-SCA can help restore skin health.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

High BMI worsens hair growth in women with PCOS.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Check hormone levels in older women to find hidden conditions like certain tumors.